Breaking News

Emergex receives Innovate UK Grant to progress flu vaccine

The biotechnology company, which is aiming to find a new approach to vaccine development, has received a grant to ...

GE accelerates production of viral vector based therapeutics

GE Healthcare has launched a new factory-in-a-box, designed to accelerate the manufacture of products requiring a ...

Merck helps accelerate global access to affordable vaccines

Merck, a leading science and technology company, has announced a partnership with Oxford University’s Jenner Institute ...

Move toward cell-based manufacturing signals opening in vaccine market

Global investments and initiatives by governmental and non-governmental organisations are bringing considerable growth ...

Sanofi to invest €350 million in Canadian vaccine facility

Expansion demonstrates company's commitment to innovation and leadership in global public health

Emergex progresses its synthetic vaccine development pipeline

Pioneering a simple, inexpensive and fast approach to vaccine development using 100% synthetic vaccine constructs to ...

Bavarian Nordic partners with US DoD to combat equine encephalitis

Signing of a new alliance for the development of a prophylactic vaccine against the equine encephalitis virus

Poor flu vaccine efficacy necessitates manufacturing shift

According to GlobalData, a data and analytics company, the poor seasonal influenza vaccine efficacy means a shift away ...

Using electrons to inactivate viruses in vaccines

Four institutes associated with the Fraunhofer Gesellschaft in Germany have been investigating new techniques to make ...

A precision medicine approach to developing cancer vaccines

Modern anticancer medicines represent a significant improvement on one-size-fits-all chemotherapy, reports Dr Sarah ...

Prokarium secures $10 million for thermostable vaccine development

Prokarium, a UK-based synthetic biology company and developer of Vaxonella, an oral, thermostable vaccine delivery ...

Measles vaccine increases child survival beyond measles protection

New study shows all-cause mortality is significantly lower when a child's most recent immunisation is a measles vaccine